OAM
SRDX

Oxford Asset Management’s Surmodics SRDX Stock Holding History

Oxford Asset Management’s Portfolio SRDX Stock Details SRDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-26,633
Closed -$1.12M – 437
2024
Q2 		$1.12M Buy
+26,633
New +$909K 1.09% 15
2020
Q1 		– Sell
-9,764
Closed -$405K – 1158
2019
Q4 		$405K Sell
9,764
-2,447
-20% -$103K 0.01% 1327
2019
Q3 		$559K Buy
+12,211
New +$532K 0.01% 1224
2019
Q2 		– Sell
-23,322
Closed -$1.01M – 1944
2019
Q1 		$1.01M Buy
+23,322
New +$1.19M 0.02% 926
2018
Q4 		– Sell
-47,630
Closed -$3.53M – 2086
2018
Q3 		$3.53M Sell
47,630
-19,062
-29% -$1.31M 0.07% 363
2018
Q2 		$3.68M Buy
66,692
+12,410
+23% +$573K 0.07% 313
2018
Q1 		$2.06M Sell
54,282
-12,097
-18% -$375K 0.04% 553
2017
Q4 		$1.87M Sell
66,379
-5,576
-8% -$170K 0.04% 610
2017
Q3 		$2.24M Sell
71,955
-8,619
-11% -$234K 0.04% 568
2017
Q2 		$2.27M Sell
80,574
-5,532
-6% -$134K 0.05% 545
2017
Q1 		$2.07M Sell
86,106
-10,615
-11% -$260K 0.05% 462
2016
Q4 		$2.46M Sell
96,721
-13,545
-12% -$356K 0.09% 262
2016
Q3 		$3.32M Buy
110,266
+30,203
+38% +$830K 0.1% 260
2016
Q2 		$1.88M Sell
80,063
-2,265
-3% -$49.6K 0.06% 378
2016
Q1 		$1.52M Sell
82,328
-10,833
-12% -$204K 0.04% 421
2015
Q4 		$1.9M Buy
93,161
+2,965
+3% +$63K 0.04% 413
2015
Q3 		$1.97M Sell
90,196
-31,684
-26% -$744K 0.06% 292
2015
Q2 		$2.85M Buy
121,880
+27,791
+30% +$697K 0.08% 276
2015
Q1 		$2.45M Sell
94,089
-29,616
-24% -$705K 0.06% 322
2014
Q4 		$2.73M Buy
123,705
+64,400
+109% +$1.36M 0.06% 313
2014
Q3 		$1.11M Sell
59,305
-12,318
-17% -$246K 0.03% 462
2014
Q2 		$1.51M Buy
71,623
+44,492
+164% +$953K 0.05% 431
2014
Q1 		$613K Sell
27,131
-36,271
-57% -$886K 0.02% 506
2013
Q4 		$1.55M Sell
63,402
-26,204
-29% -$618K 0.04% 457
2013
Q3 		$2.13M Sell
89,606
-56,288
-39% -$1.21M 0.05% 439
2013
Q2 		$2.92M Buy
+145,894
New +$3.65M 0.08% 389

Other funds holding SRDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $111M AUM 205.39% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
TI
Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Oxford Asset Management's SRDX Position: Q3 2024 in Review

Oxford Asset Management sold out of Surmodics (SRDX) in Q3 2024, closing a stake of 26,633 shares — an estimated $1.12M sold.

Oxford Asset Management first reported a position in SRDX in Q2 2013 and held it in 26 quarters. The position peaked at $3.68M in Q2 2018. 126 funds tracked by Wall St. Rank hold SRDX as of Q3 2024.

  • Oxford Asset Management reported no remaining Surmodics position as of Q3 2024 after selling out during the quarter.
  • Oxford Asset Management sold 26,633 Surmodics shares in Q3 2024, an estimated $1.12M.
  • Oxford Asset Management first reported a position in Surmodics in Q2 2013 and held it in 26 quarters.
  • Oxford Asset Management's Surmodics position peaked at $3.68M in Q2 2018.
  • 126 funds tracked by Wall St. Rank held Surmodics as of Q3 2024.

Based on Oxford Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.